Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants. [electronic resource]
Producer: 20120612Description: 707-10 p. digitalISSN:- 1523-6838
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Atypical Hemolytic Uremic Syndrome
- Comorbidity
- Hemolytic-Uremic Syndrome -- drug therapy
- Humans
- Infant, Newborn
- Male
- Plasma Exchange -- adverse effects
- Thrombotic Microangiopathies -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.